1,25-Dihydroxy_NN
vitamin_NN
D3_NN
and_CC
12-O-tetradecanoyl_NN
phorbol-13-acetate_NN
synergistically_RB
induce_VBP
monocytic_JJ
cell_NN
differentiation_NN
:_:
FOS_NN
and_CC
RB_NN
expression_NN
._.

1,25-dihydroxy_NN
vitamin_NN
D3_NN
and_CC
12-O-tetradecanoyl_NN
phorbol-13-acetate_NN
-LRB-_-LRB-
TPA_NN
-RRB-_-RRB-
interact_VBP
synergistically_RB
to_TO
induce_VB
monocytic_JJ
differentiation_NN
of_IN
U937_NN
histiocytic_JJ
lymphoma_NN
cells_NNS
._.

Addition_NN
of_IN
TPA_NN
causes_VBZ
an_DT
otherwise_RB
ineffective_JJ
dose_NN
of_IN
1,25-dihydroxy_NN
vitamin_NN
D3_NN
to_TO
induce_VB
differentiation_NN
._.

The_DT
induced_VBN
differentiation_NN
depends_VBZ
on_IN
the_DT
simultaneous_JJ
-LRB-_-LRB-
vs._CC
sequential_JJ
-RRB-_-RRB-
presence_NN
of_IN
both_DT
agents_NNS
._.

The_DT
kinetics_NNS
of_IN
induced_JJ
differentiation_NN
are_VBP
consistent_JJ
with_IN
a_DT
G1_NN
specific_JJ
cellular_JJ
response_NN
to_TO
initiate_VB
the_DT
metabolic_JJ
cascade_NN
culminating_VBG
in_IN
cell_NN
differentiation_NN
._.

The_DT
induced_VBN
differentiation_NN
occurs_VBZ
with_IN
down-regulation_NN
of_IN
c-fos_NN
protein_NN
and_CC
an_DT
accompanying_VBG
up-regulation_NN
of_IN
RB_NN
protein_NN
expression_NN
,_,
consistent_JJ
with_IN
a_DT
possible_JJ
need_NN
for_IN
up-regulated_JJ
RB_NN
expression_NN
to_TO
maintain_VB
a_DT
given_JJ
differentiated_VBN
phenotype_NN
and_CC
suppress_VB
transcriptional_JJ
activators_NNS
that_WDT
might_MD
typically_RB
be_VB
associated_VBN
with_IN
proliferation_NN
._.

